Lattice Biologics Ltd. LBLTF
OTC PK
| 06/30/2021 | 03/31/2021 | ||||
|---|---|---|---|---|---|
| Net Income | 91.93% | 51.11% | |||
| Total Depreciation and Amortization | -- | -186.37% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -24.73% | -111.94% | |||
| Change in Net Operating Assets | -- | -81.14% | |||
| Cash from Operations | 102.25% | -1,487.66% | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -- | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | 307.77% | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -766.25% | 1,579.53% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -389.47% | 508.24% | |||